FY24 revenue consensus $20.18B. Now sees FY24: Net sales growth of 3% to 5% (versus 2% to 5% previously) including a mid-single-digit negative impact from foreign exchange. The company now expects organic sales growth of 7% to 8% (versus 6% to 8% previously). On a GAAP basis, the company still expects gross profit margin expansion, increased advertising investment and double-digit earnings per share growth. On a non-GAAP (Base Business) basis, the company still expects gross profit margin expansion and increased advertising investment and now expects earnings per share growth of 10% to 11% (versus 8% to 11% previously).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CL:
- Notable companies reporting before tomorrow’s open
- Is CL a Buy, Before Earnings?
- Colgate-Palmolive price target raised to $114 from $113 at JPMorgan
- Colgate Palmolive call volume above normal and directionally bullish
- Colgate-Palmolive initiated with an Overweight at Piper Sandler
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
